Patent · US Expired

C2-disubstituted indan-1-ol compounds, their derivatives, processes for their preparation, and their use as pharmaceuticals

US6982353B2 · kind B2 · utility

0Cited by

6References

6Claims

0Family size

Assignee

Aventis Pharma Deutschland GmbH · DE

Inventors

Gerhard Jaehne · Frankfurt, DE
Volker Krone · Flörsheim, DE
Martin Bickel · Frankfurt am Main, DE
Matthias G ssel · Hofheim, DE

Key dates

Filing date	Aug 29, 2002
Grant date	Jan 3, 2006
Priority date	—
Expiry date	Aug 29, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to C2-disubstituted indan-1-ol systems of the Formula I, physiologically acceptable salts and physiologically functional derivatives thereof, and pharmaceutical compositions comprising such compounds, salts, and derivatives, which are useful for reducing weight, for the prophylaxis or treatment of obesity, and for the prophylaxis or treatment of type II diabetes in mammals. The invention is directed also to methods for reducing weight and such treatments and prophylaxis. The invention is directed also to processes for the preparation of such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.